Study on the Effects of ATL1102 for Nonambulatory Patients with Duchenne Muscular Dystrophy
BulgariaStudy on the Effectiveness and Safety of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)
DenmarkStudy on the Safety and Effects of Delandistrogene Moxeparvovec in Children Under 4 with Duchenne Muscular Dystrophy
BelgiumLong-Term Safety Study of Avalglucosidase Alfa for Patients with Pompe Disease in France
FranceStudy on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients
DenmarkStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
AustriaStudy on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies
SpainStudy on Baricitinib for Treating New-Onset Juvenile Dermatomyositis in Children
FranceStudy on the Effects of Satralizumab in Children and Adolescents with Duchenne Muscular Dystrophy
DenmarkStudy on DMD06-MAB Injection for Duchenne Muscular Dystrophy in Non-Ambulant Patients
ItalyStudy on Long-Term Safety and Effectiveness of Vamorolone in Boys with Duchenne Muscular Dystrophy Who Completed Previous Vamorolone Studies
BelgiumStudy on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping
Czechiapowered by
